Journal article icon

Journal article

The protocol of a clinical effectiveness trial comparing standard step-up care, early combination DMARD therapy and early use of TNF inhibitors for the treatment of moderate to severe psoriatic arthritis: the 3-arm parallel group SPEED randomized controlled trial

Abstract:

Objectives:: The aim of the Severe Psoriatic arthritis – Early intervEntion to control Disease trial is to compare outcomes in psoriatic arthritis (PsA) patients with poor prognostic factors treated with standard step-up conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs), combination csDMARDs or a course of early biologics. Design:: This multicentre UK trial was embedded within the MONITOR-PsA cohort, which uses a trial within cohort design. Methods and analysis:: Patien...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1177/1759720x241240913

Authors


More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0001-8570-2113
More by this author
Role:
Author
ORCID:
0000-0001-7531-4125
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-3205-6706
More by this author
Institution:
University of Oxford
Role:
Author
ORCID:
0000-0003-4618-774X
More from this funder
Funder identifier:
https://doi.org/10.13039/100006483
Publisher:
SAGE Publications
Journal:
Therapeutic Advances in Musculoskeletal Disease More from this journal
Volume:
16
Article number:
1759720X241240913
Publication date:
2024-05-30
Acceptance date:
2024-03-04
DOI:
EISSN:
1759-7218
Language:
English
Keywords:
Source identifiers:
2012304
Deposit date:
2024-06-01

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP